Hydrochloric Acid

Hydrochloric Acid

SCHEMBL909310

CC(=O)Oc1ccc2cc(C(=O)O)ccc2c1.Cl

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 3/20 0.56
GLA known ✓ P06280 1/20 0.49
FLT3 known ✓ P36888 1/20 0.47
CA2 known ✓ P00918 1/20 0.46
KDM4E B2RXH2 4/20 0.66
HSD17B10 Q99714 2/20 0.61
TSHR P16473 2/20 0.56
ALDH1A1 P00352 1/20 0.56
RAB9A P51151 1/20 0.56
LMNA P02545 2/20 0.55
ELANE P08246 1/20 0.53
CA12 O43570 2/20 0.51
CA9 Q16790 2/20 0.51
TDP1 Q9NUW8 2/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
CA1 P00915 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL908522 0.98 KDM4E (0.68) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL29714473 0.98 KDM4E (0.68) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL9339665 0.95 KDM4E (0.64) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL9702108 0.86 HSD17B10 (0.62) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL12268640 0.85 CA12 (0.54) KDM4EHSD17B10GAAALDH1A1RAB9A
SCHEMBL5045660 0.85 HSD17B10 (0.75) KDM4EHSD17B10GAATSHRALDH1A1
Isophthalic Acid SCHEMBL10627291 0.85 LMNA (0.63) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL5049051 0.85 HSD17B10 (0.75) KDM4EHSD17B10GAATSHRALDH1A1
SCHEMBL30595409 0.84 CA12 (0.65) KDM4EGAAALDH1A1LMNAELANE
SCHEMBL3974361 0.84 CA12 (0.65) KDM4EGAAALDH1A1LMNAELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531691-B2 Method for producing naphthalene carboxylic acid amide compound UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2009-05-12 US claimed
US-20080045720-A1 Method for producing naphthalene carboxylic acid amide compound UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2008-02-21 US claimed
EP-1867629-A2 Method for producing naphthalene carboxylic acid amide compound Ueno Fine Chemicals Industry, Ltd. (JP) 2007-12-19 EP claimed
US-10703917-B2 Coating compositions suitable for use with an overcoated photoresist ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2020-07-07 US disclosed
US-20170313889-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2017-11-02 US disclosed
US-9708493-B2 Coating compositions suitable for use with an overcoated photoresist ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2017-07-18 US disclosed
US-20160009924-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2016-01-14 US disclosed
US-8883407-B2 Coating compositions suitable for use with an overcoated photoresist ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2014-11-11 US disclosed
US-20110003250-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2011-01-06 US disclosed
EP-2261738-A2 Coating compositions suitable for use with an overcoated photoresist Rohm and Haas Electronic Materials, L.L.C. (US) 2010-12-15 EP disclosed
US-7531691-B2 Method for producing naphthalene carboxylic acid amide compound UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2009-05-12 US disclosed
US-20080045720-A1 Method for producing naphthalene carboxylic acid amide compound UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2008-02-21 US disclosed
EP-1867629-A2 Method for producing naphthalene carboxylic acid amide compound Ueno Fine Chemicals Industry, Ltd. (JP) 2007-12-19 EP disclosed
EP-0462578-B1 Mesomorphic compound for use in liquid crystal composition and liquid crystal device and display apparatus using same CANON KK (JP) 1999-09-22 EP disclosed
US-5244596-A Benzoxazoles CANON KABUSHIKI KAISHA (JP) 1993-09-14 US disclosed
EP-0462578-A1 Mesomorphic compound for use in liquid crystal composition and liquid crystal device and display apparatus using same CANON KABUSHIKI KAISHA (JP) 1991-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003250-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST DHPS, HAAO, FTO GAA 2304/4885GLA 1394/4885FLT3 4770/4885
US-10703917-B2 Coating compositions suitable for use with an overcoated photoresist DHPS, HAAO, FTO GAA 2304/4885GLA 1394/4885FLT3 4770/4885
US-20170313889-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST DHPS, HAAO, FTO GAA 2304/4885GLA 1394/4885FLT3 4770/4885
US-20160009924-A1 COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST DHPS, HAAO, FTO GAA 2304/4885GLA 1394/4885FLT3 4770/4885
US-20080045720-A1 Method for producing naphthalene carboxylic acid amide compound NAAA, AADAC, NAT1 GAA 593/4885GLA 920/4885FLT3 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.